Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Gilead Sciences, Inc shares valued at $20,098,464 were purchased by GILEAD SCIENCES, INC. on Dec 19 ’24. At $21.37 per share, GILEAD SCIENCES, INC. acquired 940,499 shares. The insider’s holdings grew to 2,209,471 shares worth approximately $207.58 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GILEAD SCIENCES, INC. purchased 1,759,978 shares, netting a total of over 1,830,377 in proceeds. Following the buying of shares at $1.04 each, the insider now holds 9,105,451 shares.
Before that, Dickinson Andrew D had sold 8,500 shares from its account. In a trade valued at $781,660, the Chief Financial Officer traded Gilead Sciences, Inc shares for $91.96 each. Upon closing the transaction, the insider’s holdings decreased to 8,500 shares, worth approximately $12.44 million.
Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of November 14, 2024, Citigroup has initiated its “Buy” rating for GILD. Earlier on November 08, 2024, Maxim Group downgraded its rating. Their new recommendation was “a Hold” for GILD stock which previously was a “a Buy”.
Analyzing GILD Stock Performance
During the last five days, there has been a surge of approximately 1.08%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 15.79%. Shares of the company reached a 52-week high of $98.90 on 11/11/24 and a 52-week low of $62.07 on 05/31/24. A 50-day SMA is recorded $90.83, while a 200-day SMA reached $77.17. Nevertheless, trading volume fell to 2.11 million shares from 4.81 million shares the previous day.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 92.68, which, if violated, would cause prices to drop to 91.42. In the upper region, resistance lies at 94.63. The next price resistance is at 95.32. RSI (Relative Strength Index) is 58.45 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.05, which suggests the price will increase in the coming days. Percent R is at 12.73%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
